Quantcast
Last updated on April 24, 2014 at 11:56 EDT

Latest Connective tissue diseases Stories

2012-02-21 07:00:00

HAYWARD, Calif., Feb. 21, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended December 31, 2011. Financial Results: Total operating expenses for the fourth quarter ended December 31, 2011 were $28.4 million, as compared to $12.9 million for the same period in 2010. For the 12 months ended December 31, 2011, total operating expenses were $93.1 million, as compared to $35.8 million for the same...

2012-02-20 05:00:00

West Penn Allegheny Health System physicians were instrumental in the development and trials of a new diagnostic test that pinpoints proteins which are useful in ruling-in lupus and ruling-out similar Disorders. The Avise-SLE blood is now commerically available nationwide. Pittsburgh, PA (PRWEB) February 20, 2012 A new blood test designed by physicians and scientists from the West Penn Allegheny Health System to help clinicians diagnose lupus with greater ease and accuracy is now...

2012-02-16 15:10:00

NEW YORK, Feb. 16, 2012 /PRNewswire/ -- The Lupus Research Institute (LRI) and its National Coalition of lupus patient advocacy organizations congratulate U.S. Representatives Tom Rooney (R-FL), William Keating (D-MA), Ileana Ros-Lehtinen (R-FL), and Jim Moran (D-VA) on co-chairing a new Congressional Lupus Caucus to apprise Members of Congress of the critical issues impacting lupus sufferers. "These Members of Congress are to be applauded for coming together on a...

2012-02-16 14:06:58

Higher rates of infertility and pregnancy loss likely behind lower than desired family size New research shows that more than half of women with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) have fewer children than desired. While patient choice has some influence on the smaller family size, findings published today in Arthritis Care & Research, a journal of the American College of Rheumatology (ACR), suggest that higher rates of infertility and miscarriage may also...

2012-02-16 05:30:00

ANAHEIM, Calif., Feb. 16, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced the appointment of Scott M. Whitcup, M.D., 52, to its Board of Directors. Dr. Whitcup is currently Executive Vice President, Research & Development and Chief Scientific Officer at Allergan, Inc. In that position, he is responsible for leading Allergan's global research and development organization, including medical affairs, drug discovery and medical device research,...

2012-02-15 09:22:00

NEW YORK, Feb. 15, 2012 /PRNewswire/ -- The Lupus Research Institute (LRI) today awards 12 "Novel Research Grants" to jumpstart discovery in lupus by supporting original, highly promising ideas from some of the country's most creative scientists. Studies will look at why lupus turns the body's immune system against itself and pioneer strategies for new treatment development. The new awards represent diverse disciplines, from inflammation and medical imaging to evolutionary biology and the...

2012-02-13 15:04:02

Increase not necessarily linked to arthritis treatments, including TNF inhibitors New research reports that incident malignancy among children with juvenile idiopathic arthritis (JIA) is four times higher than in those without the disease. Findings now available in Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR), suggest JIA treatment, such as tumor necrosis factor (TNF) inhibitors, does not necessarily explain the...

2012-02-10 05:30:00

ANAHEIM, Calif., Feb. 10, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) announced today that executive management will present at the Leerink Swann Global Healthcare Conference to be held on February 15-16, 2012 in New York. Steve Cartt, Executive Vice President and Chief Business Officer, is scheduled to present an overview of the Company on Thursday, February 16, 2012 at 2:30 p.m. ET. A live webcast and subsequent archived replay of the presentation will be...

2012-02-09 16:00:00

HAYWARD, Calif., Feb. 9, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, will release its fourth quarter 2011 financial report before the market opens on Tuesday, February 21, 2012. Anthera will host a conference call at 1 pm Eastern Time in conjunction with the release. The Company will also provide an update for both the varespladib and blisibimod clinical...

2012-02-03 14:00:00

National Congressional Call-in Day Wednesday, Feb. 8 DANVERS, Mass., Feb. 3, 2012 /PRNewswire-USNewswire/ -- The Scleroderma Foundation unveiled a unique awareness campaign today with the help of OrgSpring, an online technology firm that helps nonprofit organizations build and maintain relationships with supporters. Through the campaign, people living with scleroderma, their family members, friends and others are urged to change their Facebook Profile Timeline cover images in...